These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 33503583)

  • 41. Non-communicable diseases as a major contributor to deaths in 12 tribal districts in India.
    Kaur P; Borah PK; Uike PV; Mohapatra PK; Das NK; Gaigaware P; Tobgay KJ; Tushi A; Zorinsangi ; Mazumdar G; Marak B; Pizi D; Chakma T; Sugunan AP; Vijayachari P; Bhardwaj RR; Arambam PC; Kutum T; Sharma A; Pal P; Shanmugapriya PC; Manivel P; Kaliyamoorthy N; Chakma J; Mathur P; Dhaliwal RS; Mahanta J; Mehendale SM
    Indian J Med Res; 2022 Aug; 156(2):250-259. PubMed ID: 36629184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. District-level epidemiology and sociodemographic determinants of noncommunicable diseases - results the National Family Health Survey -5 (2019-21).
    Kulothungan V; Mascarenhas L; Das P; Mathur P
    Diabetes Metab Syndr; 2024 Jul; 18(7):103085. PubMed ID: 39084053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Patient-provider experiences with chronic non-communicable disease care during COVID-19 lockdowns in rural Uganda: A qualitative analysis.
    Olds PK; Nuwagaba G; Obwoya PS; Nuwagira E; Haberer JE; Okello S
    PLoS One; 2023; 18(12):e0295596. PubMed ID: 38096188
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Excess mortality associated with the COVID-19 pandemic in Latvia: a population-level analysis of all-cause and noncommunicable disease deaths in 2020.
    Gobiņa I; Avotiņš A; Kojalo U; Strēle I; Pildava S; Villeruša A; Briģis Ģ
    BMC Public Health; 2022 Jun; 22(1):1109. PubMed ID: 35659648
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterizing a two-pronged epidemic in Mexico of non-communicable diseases and SARS-Cov-2: factors associated with increased case-fatality rates.
    Monterrubio-Flores E; Ramírez-Villalobos MD; Espinosa-Montero J; Hernandez B; Barquera S; Villalobos-Daniel VE; Campos-Nonato I
    Int J Epidemiol; 2021 May; 50(2):430-445. PubMed ID: 33585901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. COVID-19: Are Non-Communicable Diseases Risk Factors for Its Severity?
    Bello B; Useh U
    Am J Health Promot; 2021 Jun; 35(5):720-729. PubMed ID: 33576237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-communicable diseases, food and nutrition in Vietnam from 1975 to 2015: the burden and national response.
    Nguyen TT; Hoang MV
    Asia Pac J Clin Nutr; 2018; 27(1):19-28. PubMed ID: 29222878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Access to Medicines for Non-Communicable Diseases (NCDS) during COVID-19 in Kenya: A Descriptive Commentary.
    Kiragu ZW; Gathecha G; Mwangi MK; Ndegwa Z; Pastakia S; Nyagah D; Cizungu RN; Takah Mutwiri M; Ndolo M; Wirtz VJ
    Health Syst Reform; 2021 Jan; 7(1):e1984865. PubMed ID: 34748436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Towards the Development of an Intervention to Address Social Determinants of Non-Communicable Disease in Kerala, India: A Mixed Methods Study.
    Webber M; Joubert J; Fendt-Newlin M; Madavanakadu Devassy S; Scaria L; Benny AM; Joubert L
    Int J Environ Res Public Health; 2020 Nov; 17(22):. PubMed ID: 33233789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Equity in distribution of public subsidy for noncommunicable diseases among the elderly in India: an application of benefit incidence analysis.
    Bose M; Banerjee S
    BMC Public Health; 2019 Dec; 19(1):1735. PubMed ID: 31878911
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Unconditional probability of dying and age-specific mortality rate because of major non-communicable diseases in India: Time trends from 2001 to 2013.
    Reddy MM; Kar SS
    J Postgrad Med; 2019; 65(1):11-17. PubMed ID: 29943745
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Obesity and diabetes as high-risk factors for severe coronavirus disease 2019 (Covid-19).
    Zhou Y; Chi J; Lv W; Wang Y
    Diabetes Metab Res Rev; 2021 Feb; 37(2):e3377. PubMed ID: 32588943
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence of risk factors for non-communicable diseases in a rural tribal population of Mokokchung, Nagaland, India.
    Tushi A; Rao SR; Pattabi K; Kaur P
    Natl Med J India; 2018; 31(1):11-14. PubMed ID: 30348915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Cross-sectional Assessment of Risk Factors of Non-Communicable Diseases in a Sub-Himalayan Region of West Bengal, India Using who Steps Approach.
    Bhattacherjee S; Datta S; Roy JK; Chakraborty M
    J Assoc Physicians India; 2015 Dec; 63(12):34-40. PubMed ID: 27666902
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Avoiding a legacy of unequal non-communicable disease burden after the COVID-19 pandemic.
    Maani N; Abdalla SM; Galea S
    Lancet Diabetes Endocrinol; 2021 Mar; 9(3):133-135. PubMed ID: 33549161
    [No Abstract]   [Full Text] [Related]  

  • 56. Baseline risk factor prevalence among adolescents aged 15-17 years old: findings from National Non-communicable Disease Monitoring Survey (NNMS) of India.
    Mathur P; Kulothungan V; Leburu S; Krishnan A; Chaturvedi HK; Salve HR; Amarchand R; Nongkynrih B; Ganeshkumar P; Urs K S V; Laxmaiah A; Boruah M; Kumar S; Patro BK; Raghav PR; Rajkumar P; Sarma PS; Sharma R; Tambe M; Arlappa N; Mahanta TG; Bhuyan PJ; Joshi RP; Pakhare A; Galhotra A; Kumar D; Behera BK; Topno RK; Gupta MK; Rustagi N; Trivedi AV; Thankappan KR; Gupta S; Garg S; Shelke SC;
    BMJ Open; 2021 Jun; 11(6):e044066. PubMed ID: 34187814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review.
    Chang AY; Cullen MR; Harrington RA; Barry M
    J Intern Med; 2021 Apr; 289(4):450-462. PubMed ID: 33020988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The burden of hypertension in KwaZulu-Natal Province, South Africa: A 6-year perspective.
    Pillay S; Pillay D; Pillay RS
    S Afr Med J; 2021 Feb; 111(2):159-165. PubMed ID: 33944727
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa.
    Spearman CW; Abdo A; Ambali A; Awuku YA; Kassianides C; Lesi OA; Ndomondo-Sigonda M; Onyekwere CA; Rwegasha J; Shewaye AB; Sonderup MW;
    Lancet Gastroenterol Hepatol; 2021 Dec; 6(12):1047-1056. PubMed ID: 34508669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Healthcare resource utilisation for chronic kidney disease and other major non-communicable chronic diseases in China: a cross-sectional study.
    Yang C; Long J; Shi Y; Zhou Z; Wang J; Zhao MH; Wang H; Zhang L; Coresh J
    BMJ Open; 2022 Jan; 12(1):e051888. PubMed ID: 35027417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.